MeiraGTx Insider Trades
NASDAQ: MGTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 11 · $5.20M
- Shares bought / sold
- 0 / 498.98K
- Net activity
- Net selling $5.2 million
MeiraGTx insider activity
Over the last 12 months, MeiraGTx insiders reported 44 transactions on SEC Form 4: 0 open-market purchases and 11 sales. Insiders bought $0 and sold $5.2 million worth of stock, for net insider selling of $5.2 million. The largest seller was Forbes Alexandria, with $2.4 million in reported sales.
The most recent filing shows Forbes Alexandria (PRESIDENT & CEO) reporting a transaction in 24,100 shares on Nov 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MGTX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
MGTX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 17, 2026 | Forbes AlexandriaPRESIDENT & CEO | Sale | 62,000 | $523.90K | Form 4 |
| Nov 17, 2026 | Forbes AlexandriaPRESIDENT & CEO | Gift | 24,100 | — | Form 4 |
| Oct 20, 2026 | Giroux RichardCFO & COO | Sale | 56,000 | $557.20K | Form 4 |
| Oct 6, 2026 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Sale | 27,659 | $294.29K | Form 4 |
| Aug 18, 2026 | Forbes AlexandriaPRESIDENT & CEO | Sale | 62,000 | $859.32K | Form 4 |
| Jul 21, 2026 | Giroux RichardCFO & COO | Sale | 56,000 | $700.56K | Form 4 |
| Jul 7, 2026 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Sale | 25,112 | $374.17K | Form 4 |
| Jul 7, 2026 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Sale | 2,547 | $35.30K | Form 4 |
| Jun 10, 2026 | Harris Keith R.Director | Option exercise | 75,000 | — | Form 4 |
| May 27, 2026 | Giroux RichardCFO & COO | Gift | 7,000 | — | Form 4 |
| May 19, 2026 | Forbes AlexandriaPRESIDENT & CEO | Sale | 62,000 | $568.54K | Form 4 |
| Apr 21, 2026 | Giroux RichardCFO & COO | Sale | 56,000 | $572.32K | Form 4 |
| Apr 17, 2026 | PERCEPTIVE ADVISORS LLC & EDELMAN JOSEPH & PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector | Award | 555,555 | $5.00M | Form 4 |
| Apr 7, 2026 | Naylor StuartCHIEF DEV. OFFICER | Sale | 27,661 | $258.91K | Form 4 |
| Mar 24, 2026 | Forbes AlexandriaPRESIDENT & CEO | Sale | 62,000 | $459.42K | Form 4 |
| Feb 21, 2026 | Forbes AlexandriaPRESIDENT & CEO | Tax withholding | 33,048 | $246.21K | Form 4 |
| Feb 21, 2026 | Forbes AlexandriaPRESIDENT & CEO | Option exercise | 62,500 | — | Form 4 |
| Feb 21, 2026 | Giroux RichardCFO & COO | Tax withholding | 31,726 | $236.36K | Form 4 |
| Feb 21, 2026 | Giroux RichardCFO & COO | Option exercise | 60,000 | — | Form 4 |
| Feb 21, 2026 | Naylor StuartCHIEF DEV. OFFICER | Tax withholding | 11,750 | $87.54K | Form 4 |
| Feb 21, 2026 | Naylor StuartCHIEF DEV. OFFICER | Option exercise | 25,000 | — | Form 4 |
| Feb 21, 2026 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | 5,949 | $44.32K | Form 4 |
| Feb 21, 2026 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | 11,250 | — | Form 4 |
| Feb 21, 2026 | Zeldin Robert KCHIEF MEDICAL OFFICER | Tax withholding | 2,952 | $21.99K | Form 4 |
| Feb 21, 2026 | Zeldin Robert KCHIEF MEDICAL OFFICER | Option exercise | 7,500 | — | Form 4 |
| Jan 17, 2026 | Forbes AlexandriaPRESIDENT & CEO | Tax withholding | 163,916 | $1.22M | Form 4 |
| Jan 17, 2026 | Forbes AlexandriaPRESIDENT & CEO | Option exercise | 310,000 | — | Form 4 |
| Jan 17, 2026 | Giroux RichardCFO & COO | Tax withholding | 163,916 | $1.22M | Form 4 |
| Jan 17, 2026 | Giroux RichardCFO & COO | Option exercise | 310,000 | — | Form 4 |
| Jan 17, 2026 | Naylor StuartCHIEF DEV. OFFICER | Tax withholding | 35,250 | $261.56K | Form 4 |
| Jan 17, 2026 | Naylor StuartCHIEF DEV. OFFICER | Option exercise | 75,000 | — | Form 4 |
| Jan 17, 2026 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | 27,206 | $201.87K | Form 4 |
| Jan 17, 2026 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | 50,000 | — | Form 4 |
| Jan 17, 2026 | Zeldin Robert KCHIEF MEDICAL OFFICER | Tax withholding | 13,951 | $103.52K | Form 4 |
| Jan 17, 2026 | Zeldin Robert KCHIEF MEDICAL OFFICER | Option exercise | 35,000 | — | Form 4 |
| Jan 7, 2026 | Naylor StuartCHIEF DEV. OFFICER | Tax withholding | 17,625 | $136.24K | Form 4 |
| Jan 7, 2026 | Naylor StuartCHIEF DEV. OFFICER | Option exercise | 37,500 | — | Form 4 |
| Jan 7, 2026 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | 4,364 | $33.73K | Form 4 |
| Jan 7, 2026 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | 7,500 | — | Form 4 |
| Jan 7, 2026 | Zeldin Robert KCHIEF MEDICAL OFFICER | Tax withholding | 6,729 | $52.02K | Form 4 |
| Jan 7, 2026 | Zeldin Robert KCHIEF MEDICAL OFFICER | Option exercise | 17,500 | — | Form 4 |
| Jan 7, 2026 | Giroux RichardCFO & COO | Tax withholding | 28,822 | $222.79K | Form 4 |
| Jan 7, 2026 | Giroux RichardCFO & COO | Option exercise | 52,500 | — | Form 4 |
| Jan 7, 2026 | Zeldin Robert KCHIEF MEDICAL OFFICER | Tax withholding | 7,814 | $60.40K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4